Gwen Wyatt1, Stephanie L Pugh2, Raimond K W Wong3, Stephen Sagar3, Anurag K Singh4, Shlomo A Koyfman5, Phuc F Nguyen-Tân6, Sue S Yom7, Francis S Cardinale8, Khalil Sultanem9, Ian Hodson3, Greg A Krempl10, Barbara Lukaszczyk11, Alexander M Yeh12, Lawrence Berk13. 1. College of Nursing, Michigan State University, 1355 Bogue St. Room C345, East Lansing, MI, 48824, USA. Gwen.Wyatt@hc.msu.edu. 2. NRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA. 3. Juravinski Cancer Centre, Hamilton, ON, Canada. 4. Roswell Park Cancer Institute, Buffalo, NY, USA. 5. Cleveland Clinic, Cleveland, OH, USA. 6. Centre Hospitalier de l'Université de Montréal-Hôpital Notre-Dame, Montreal, QC, Canada. 7. University of California San Francisco, San Francisco, CA, USA. 8. Yale-New Haven Hospital Saint Raphael Campus, New Haven, CT, USA. 9. McGill University, Montreal, QC, Canada. 10. University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. 11. John H. Stroger, Jr. Hospital of Cook County MB-CCOP, Chicago, IL, USA. 12. Indiana University Hospital/Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA. 13. University of South Florida H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Abstract
PURPOSE: The purpose of this secondary analysis was to determine change in overall health-related quality of life (HRQOL) based on patient data obtained from NRG Oncology RTOG 0537 as measured by the RTOG-modified University of Washington Head and Neck Symptom Score (RM-UWHNSS). METHODS: A multi-site prospective randomized clinical trial design stratified 137 patients with post-radiation therapy xerostomia according to priorpilocarpine (PC) treatment and time after radiation therapy and/or chemotherapy and randomized patients into two groups. Patients were assigned to acupuncture or PC. Twenty-four sessions of acupuncture-like transcutaneous electrical nerve stimulation (ALTENS) were administered over 12 weeks, or oral PC (5 mg) three times daily over the same 12 weeks. The RM-UWHNSS was administered at baseline and at 4, 6, 9, and 15 months after the date of randomization. RESULTS: There were no between-arm differences in change scores on the RM-UWHNSS in the individual items, total score, or factor scores. For statistical modeling, race and time were significant for all outcomes (total and factor scores), while treatment arm was not significant. The ALTENS arm showed greater yet nonsignificant improvement in outcomes compared to the PC arm. CONCLUSION: Although no significant treatment differences were seen in this trial, patients receiving ALTENS consistently had lower scores, indicating better function, as compared to those receiving PC. Radiation-induced xerostomia improved over time for all patients.
RCT Entities:
PURPOSE: The purpose of this secondary analysis was to determine change in overall health-related quality of life (HRQOL) based on patient data obtained from NRG Oncology RTOG 0537 as measured by the RTOG-modified University of Washington Head and Neck Symptom Score (RM-UWHNSS). METHODS: A multi-site prospective randomized clinical trial design stratified 137 patients with post-radiation therapy xerostomia according to prior pilocarpine (PC) treatment and time after radiation therapy and/or chemotherapy and randomized patients into two groups. Patients were assigned to acupuncture or PC. Twenty-four sessions of acupuncture-like transcutaneous electrical nerve stimulation (ALTENS) were administered over 12 weeks, or oral PC (5 mg) three times daily over the same 12 weeks. The RM-UWHNSS was administered at baseline and at 4, 6, 9, and 15 months after the date of randomization. RESULTS: There were no between-arm differences in change scores on the RM-UWHNSS in the individual items, total score, or factor scores. For statistical modeling, race and time were significant for all outcomes (total and factor scores), while treatment arm was not significant. The ALTENS arm showed greater yet nonsignificant improvement in outcomes compared to the PC arm. CONCLUSION: Although no significant treatment differences were seen in this trial, patients receiving ALTENS consistently had lower scores, indicating better function, as compared to those receiving PC. Radiation-induced xerostomia improved over time for all patients.
Entities:
Keywords:
Acupuncture-like transcutaneous electrical nerve stimulation (ALTENS); Head and neck cancer; Radiation-induced xerostomia (RIX); Symptom management
Authors: Raimond K W Wong; Snehal Deshmukh; Gwen Wyatt; Stephen Sagar; Anurag K Singh; Khalil Sultanem; Phuc F Nguyen-Tân; Sue S Yom; Joseph Cardinale; Min Yao; Ian Hodson; Chance L Matthiesen; John Suh; Harish Thakrar; Stephanie L Pugh; Lawrence Berk Journal: Int J Radiat Oncol Biol Phys Date: 2015-04-01 Impact factor: 7.038
Authors: C Delporte; B C O'Connell; X He; H E Lancaster; A C O'Connell; P Agre; B J Baum Journal: Proc Natl Acad Sci U S A Date: 1997-04-01 Impact factor: 11.205
Authors: Jeff A Sloan; Lawrence Berk; Joseph Roscoe; Michael J Fisch; Edward G Shaw; Gwen Wyatt; Gary R Morrow; Amylou C Dueck Journal: J Clin Oncol Date: 2007-11-10 Impact factor: 44.544
Authors: Karen E Hoffman; Stephanie L Pugh; Jennifer L James; Charles Scarantino; Benjamin Movsas; Richard K Valicenti; Andre Fortin; JonDavid Pollock; Harold Kim; David G Brachman; Lawrence B Berk; Deborah Watkins Bruner; Lisa A Kachnic Journal: Qual Life Res Date: 2014-02-04 Impact factor: 4.147
Authors: Isabelle M A Lombaert; Pieter K Wierenga; Tineke Kok; Harm H Kampinga; Gerald deHaan; Robert P Coppes Journal: Clin Cancer Res Date: 2006-03-15 Impact factor: 12.531
Authors: Raimond K W Wong; Glenn W Jones; Stephen M Sagar; Angelica-Fargas Babjak; Tim Whelan Journal: Int J Radiat Oncol Biol Phys Date: 2003-10-01 Impact factor: 7.038
Authors: Austin J Iovoli; Alexander Ostrowski; Charlotte I Rivers; Gregory M Hermann; Adrienne Groman; Austin Miller; Anurag K Singh Journal: J Altern Complement Med Date: 2020-01-27 Impact factor: 2.579
Authors: Stephanie L Pugh; Gwen Wyatt; Raimond K W Wong; Stephen M Sagar; Bevan Yueh; Anurag K Singh; Min Yao; Phuc Felix Nguyen-Tan; Sue S Yom; Francis S Cardinale; Khalil Sultanem; D Ian Hodson; Greg A Krempl; Ariel Chavez; Alexander M Yeh; Deborah W Bruner Journal: J Pain Symptom Manage Date: 2016-11-27 Impact factor: 3.612
Authors: Stephanie L Pugh; Joseph P Rodgers; Jennifer Moughan; Roseann Bonanni; Jaskaran Boparai; Ronald C Chen; James J Dignam; Deborah W Bruner Journal: Qual Life Res Date: 2020-09-07 Impact factor: 4.147